Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

The problem with composite end points in cardiovascular studies: the story of major adverse cardiac events and percutaneous coronary intervention.

Kip KE, Hollabaugh K, Marroquin OC, Williams DO.

J Am Coll Cardiol. 2008 Feb 19;51(7):701-7. doi: 10.1016/j.jacc.2007.10.034. Review.

2.

Long-term outcome of patients of over 85 years old with acute coronary syndrome undergoing percutaneous coronary stenting: a comparison of bare metal stent and drug eluting stent.

Ma HY, Zhou YJ, Dick RJ, Shi DM, Liu YY, Cheng WJ, Guo YH, Wang JL, Ge HL.

Chin Med J (Engl). 2008 May 20;121(10):887-91.

PMID:
18706201
3.

Drug-eluting stents in the elderly: long-term (> one year) clinical outcomes of octogenarians in the DESIRE (Drug-Eluting Stents In the REal world) registry.

Costa JR Jr, Sousa A, Moreira AC, Costa RA, Maldonado G, Cano MN, Egito ET, Romano ER, Barbosa M, Pavanello R, Jardim C, Cury A, Berwanger O, Sousa JE.

J Invasive Cardiol. 2008 Aug;20(8):404-10.

PMID:
18688065
4.

Clinical outcomes following drug-eluting versus bare metal stent implantation for lesion subsets excluded from pivotal clinical trials: findings from the GHOST Study (Guthrie Health System Off-Label StenT Study).

Harjai KJ, Orshaw P, Shenoy C, Acharji S, Sporn D, Aboufares A, Stapleton D.

J Interv Cardiol. 2008 Aug;21(4):315-24. doi: 10.1111/j.1540-8183.2008.00380.x. Erratum in: J Interv Cardiol. 2008 Oct;21(5):441.

PMID:
18754967
5.

Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry.

Novack V, Tsyvine D, Cohen DJ, Pencina M, Dubin J, Dehghani H, Kleiman NS, Cutlip DE.

Catheter Cardiovasc Interv. 2009 Jun 1;73(7):874-80. doi: 10.1002/ccd.21925.

PMID:
19180665
6.

Long-term outcomes of drug-eluting versus bare-metal stent implantation in patients with chronic total coronary artery occlusions.

Han YL, Zhang J, Li Y, Wang SL, Jing QM, Yi XH, Ma YY, Luan B, Wang G, Wang B.

Chin Med J (Engl). 2009 Mar 20;122(6):643-7.

PMID:
19323927
7.

Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.

Brugaletta S, Burzotta F, Trani C, Todaro D, Talarico G, Porto I, Leone AM, Niccoli G, Mazzari MA, Mongiardo R, Schiavoni G, Crea F.

Minerva Cardioangiol. 2008 Feb;56(1):35-42.

PMID:
18432167
8.

Very late thrombosis in acute myocardial infarction: drug-eluting versus uncoated stents.

Garro N, Capodanno D, Cammalleri V, Tamburino C.

EuroIntervention. 2008 Nov;4(3):324-30.

PMID:
19110805
9.

Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.

Whan Lee C, Kim SH, Suh J, Park DW, Lee SH, Kim YH, Hong MK, Kim JJ, Park SW, Park SJ.

Catheter Cardiovasc Interv. 2008 Apr 1;71(5):594-8. doi: 10.1002/ccd.21399.

PMID:
18311841
10.

5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.

Caixeta A, Leon MB, Lansky AJ, Nikolsky E, Aoki J, Moses JW, Schofer J, Morice MC, Schampaert E, Kirtane AJ, Popma JJ, Parise H, Fahy M, Mehran R.

J Am Coll Cardiol. 2009 Sep 1;54(10):894-902. doi: 10.1016/j.jacc.2009.04.077.

11.

In-hospital complications and long-term outcomes of the paclitaxel drug-eluting stent in acute ST-elevation myocardial infarction: a real-world experience from a high-volume medical center.

Shammas NW, Shammas GA, Hahn A, Jerin M, Dippel EJ, Winter M.

Cardiovasc Revasc Med. 2009 Jul-Sep;10(3):151-5. doi: 10.1016/j.carrev.2009.01.007.

PMID:
19595395
12.

Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up.

Marcucci R, Gori AM, Paniccia R, Giusti B, Valente S, Giglioli C, Buonamici P, Antoniucci D, Abbate R, Gensini GF.

Circulation. 2009 Jan 20;119(2):237-42. doi: 10.1161/CIRCULATIONAHA.108.812636. Epub 2008 Dec 31.

13.

Outcomes of the tacrolimus drug-eluting Janus stent: a prospective two-centre registry in high-risk patients.

Romagnoli E, Leone AM, Burzotta F, Trani C, Angeloni G, Materazzo G, Niccoli G, De Vita M, Perfetti M, Mazzari MA, Mongiardo R, Rebuzzi AG, Schiavoni G, Crea F.

J Cardiovasc Med (Hagerstown). 2008 Jun;9(6):589-94. doi: 10.2459/JCM.0b013e3282f20ad1.

PMID:
18475127
14.

Clinical outcomes of drug-eluting stents compared with bare metal stents in our routine clinical practice.

Alidoosti M, Salarifar M, Haji-Zeinali AM, Kassaian SE, Dehkordi MR, Fathollahi MS.

Hellenic J Cardiol. 2008 May-Jun;49(3):132-8.

15.

Two-year clinical outcome after successful implantation of drug-eluting and bare metal stents in diabetic patients: results from a real-world single center registry.

Dou KF, Xu B, Yang YJ, Chen JL, Qiao SB, Li JJ, Qin XW, Liu HB, Wu YJ, Chen J, Yao M, You SJ, Yuan JQ, Dai J, Gao RL.

Chin Med J (Engl). 2009 Mar 20;122(6):612-6.

PMID:
19323921
16.

Long-term outcome in patients treated with sirolimus-eluting stents in complex coronary artery lesions: 3-year results of the SCANDSTENT (Stenting Coronary Arteries in Non-Stress/Benestent Disease) trial.

Kelbaek H, Kløvgaard L, Helqvist S, Lassen JF, Krusell LR, Engstrøm T, Bøtker HE, Jørgensen E, Saunamäki K, Aljabbari S, Thayssen P, Galløe A, Jensen GV, Thuesen L.

J Am Coll Cardiol. 2008 May 27;51(21):2011-6. doi: 10.1016/j.jacc.2008.01.056.

17.

Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials.

Daemen J, Boersma E, Flather M, Booth J, Stables R, Rodriguez A, Rodriguez-Granillo G, Hueb WA, Lemos PA, Serruys PW.

Circulation. 2008 Sep 9;118(11):1146-54. doi: 10.1161/CIRCULATIONAHA.107.752147. Epub 2008 Aug 25.

18.

Lack of clinical long-term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts.

Gioia G, Benassi A, Mohendra R, Chowdhury K, Masood I, Matthai W.

Catheter Cardiovasc Interv. 2008 Jul 1;72(1):13-20. doi: 10.1002/ccd.21599.

PMID:
18561143
19.

Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials.

Kirtane AJ, Ellis SG, Dawkins KD, Colombo A, Grube E, Popma JJ, Fahy M, Leon MB, Moses JW, Mehran R, Stone GW.

J Am Coll Cardiol. 2008 Feb 19;51(7):708-15. doi: 10.1016/j.jacc.2007.10.035.

20.

Paclitaxel-eluting versus bare-metal stents in acute ST elevation myocardial infarction (STEMI).

Hamirani YS, Jibrin I, Abraham D, Merriman B, Wenz C, Bahr RD.

Crit Pathw Cardiol. 2008 Dec;7(4):232-8. doi: 10.1097/HPC.0b013e3181805e0b.

PMID:
19050419

Supplemental Content

Support Center